Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Isotis outlicenses Allox

Biosurgery company IsoTis (SWX:ISON; Euronext:ISON) granted dermatologic company Healthpoint (Fort Worth, Texas) an

Read the full 136 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE